Global colorectal cancer market is driven by some of the major factors such as increasing prevalence of colorectal cancer, technological advancements in the cancer therapy, aging population, and raise in consumer awareness about colorectal cancers. However, high costs of screening tests and medicine, lack of knowledge are some of the restraints that are hampering the growth of the global colorectal cancer medicine market.A sample of this report is available upon request @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-colorectal-cancer-drugs-market/#ulp-4H8Z4LpNMLEuOnnx[/URL]
The global colorectal cancer medicine market is segmented by therapy, drug class, distribution channel, and regions.
On the basis of therapy, global colorectal cancer medicine market is segmented as
Adjuvant chemotherapy
Palliative chemotherapy
Immuno therapy
Neo adjuvant chemotherapy
On the basis of drug class, global colorectal cancer medicine market is segmented as
Capecitabine (Xeloda)
Irinotecan (Camptosar)
Fluorouracil (5-FU, Adrucil)
Trifluridine/tipiracil (TAS-102, Lonsurf)
Oxaliplatin (Eloxatin)
Others
Some common treatment regimens using these medicine include:
5-FU
Capecitabine, an oral form of 5-FU
5-FU with leucovorin (Wellcovorin), a vitamin that improves the effectiveness of 5-FU
FOLFIRI: 5-FU with leucovorin and irinotecan
FOLFOX: 5-FU with leucovorin and oxaliplatin
Irinotecan alone
XELOX/CAPEOX: Capecitabine with oxaliplatin
XELIRI/CAPIRI: Capecitabine with irinotecan
On the basis of distribution channel, the global colorectal cancer medicine market is segmented as
Retail Pharmacies
Hospital Pharmacies
Others
To view TOC of this report is available upon request @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-colorectal-cancer-drugs-market/#ulp-c654SbFYO64MsOhu[/URL]
Colorectal cancer is the third most common cancer in the world. Huge government initiatives taken by the nations are booming up the growth of the colorectal cancer medicine treatment market globally. Biologics such as Zaltrap (Ziv-Aflibercept), Erbitux (Cetuximab), Avastin (Bevacizumab) are using rapidly for the treatment for colorectal cancer that are used as a targeted therapy and they acts only on the malignant cells. Market players in the colorectal cancer medicine market forming strategic alliances and partnerships to increase their market share.
Need more information about this report @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-colorectal-cancer-drugs-market/#ulp-14mlyhjMGhVjZqa3[/URL]
Some of the players in the colorectal cancer medicine market are Amgen Inc. (U.S), Bristol-Myers Squibb Company (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Bayer AG (Germany), Merck & Co., Inc. (U.S.), and Sanofi (France) to name a few.
"Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free(US): +1-866-598-1553"